Hemostats Market Size, Share & Industry Analysis, By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), By End-User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 7.9% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Product

• Active Hemostats
• Thrombin Based Hemostats
• Fibrin Sealants
• Passive Hemostats
• Plant-based Hemostats
• Animal-based Hemostats
• Others
• Combination Hemostats
• Others

By Application

• Trauma
• Cardiovascular Surgery
• General Surgery
• Plastic Surgery
• Orthopedic Surgery
• Neurosurgery
• Others

By End-User

• Hospitals & ASCs
• Tactical Combat Casualty Care Centers
• Others

By Region

• North America (By Product, Application, End-User, and Country)
• U.S.
• Canada
• Europe (By Product, Application, End-User, and Country/Sub-region)
• U.K.
• Germany
• France
• Italy
• Spain
• Scandinavia
• Rest of Europe
• Asia Pacific (By Product, Application, End-User, and Country/Sub-region)
• China
• Japan
• India
• Australia & New Zealand
• Southeast Asia
• Rest of Asia Pacific
• Latin America (By Product, Application, End-User, and Country/Sub-region)
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa (By Product, Application, End-User, and Country/Sub-region)
• GCC
• South Africa
• Rest of Middle East & Africa